Injection device
At Love Lifesciences, we are reshaping the future of injectables in the compounding market. Our flagship innovation, UniPen, is the first therapeutic-agnostic injection system designed to optimize efficiency, safety, and precision across a diverse range of therapies.
Whether you’re compounding medications for personalized care or delivering life-enhancing treatments, UniPen elevates every step of the injectable experience.
Unipen use video
LAUNCHING WITH UNIPEN
A Platform Meeting Pharma Industry Quality and Manufacturing Standards, Designed for the Compounding Pharmacy Market
The UniPen Platform is an integrated device deployment program aligned with pharmaceutical industry standards.
UniPen provides pharmacies a streamlined pathway to launching sterile injectable products in a patient-friendly device.
By minimizing timelines and upfront costs, UniPen offers pharmacies enhanced patient satisfaction outcomes and financial benefits previously only available to pharmaceutical companies.
ABOUT US
At Love Lifesciences, we are dedicated to revolutionizing the patient injection experience for those requiring chronic injection therapeutics.
Nick Love, MD, MBA
CO-FOUNDER, CEO
- Background in Biopharma
- Business analytics & research
- Board Member – BioKansas
Bradley Hopper
CO-FOUNDER, CTO
- 10y founding & growing companies in various industries
- Background in Product Design & Engineering
Erik Blume, JD, MBA
Chief operating officer
- 10y+ working with bioscience and tech startups
- Licensed attorney
- Board Member – Bio Kansas
Richard Hollocher
Product & Systems Engineer
- Experienced mechanical engineer with a background at Honeywell and Spirit Aerosystems
Sujal Shah
Head of Growth Strategy
- 20y+ in MedTech commercial & market development strategy leadership for Johnson & Johnson, Pfizer
John Ziobro
Head of Regulatory Affairs
- 35y+ Medical Device expertise including executive management, engineering, regulatory affairs
Join our growing network of more than 130 partners, customers, and Supporting Organizations
In The News
2024 Startups to Watch: Love Lifesciences injects momentum as region doubles down on healthtech